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Background: Ageing and type 2 diabetes mellitus (T2DM) are risk factors for skeletal muscle loss. We
investigated whether anabolic resistance to feeding might underlie accelerated muscle loss in older
people with T2DM and whether dysregulated mTOR signalling was implicated.
Subjects: 8 obese men with T2DM, and 12 age-matched controls were studied (age 68 ± 3 vs. 68±6 y;
BMI: 30 ± 2 vs. 27 ± 5 kg m2).
Methods: Body composition was measured by dual-X-ray absorptiometry. Insulin and glucose were
clamped at post-absorptive concentrations (13 ± 2 vs. 9 ± 3 mU l1; 7.4 ± 1.9 vs. 4.6 ± 0.4 mmol l1; T2DM
vs. controls). Fractional synthetic rates (FSR) of myofibrillar and sarcoplasmic proteins were measured as
the rate of incorporation of [13C] leucine during a primed, constant infusion of [1e13C] a-ketoisocaproic
acid, 3 h after 10 or 20 g of essential amino acids (EAA) were orally administered. Protein expression of
total and phosphorylated mTOR signalling proteins was determined by Western blot analysis.
Results: Despite a significantly lower appendicular lean mass index and a greater fat mass index in T2DM
vs. controls, basal myofibrillar and sarcoplasmic and post-prandial myofibrillar FSR were similar. After
20 g EAA, stimulation of sarcoplasmic FSR was slightly blunted in T2DM patients. Furthermore, feeding
20 g EAA increased phosphorylation of mTOR, p70S6k and 4E-BP1 by 60e100% in controls with no
response observed in T2DM.
Conclusions: There was clear dissociation between changes in mTOR signalling versus changes in protein
synthesis rates. However, the intact anabolic response of myofibrillar FSR to feeding in both groups
suggests anabolic resistance may not explain accelerated muscle loss in T2DM.
© 2016 Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Sarcopenia is characterised by a progressive decline in skeletal
muscle mass resulting in low muscle strength and impaired phys-
ical performance [1]. The risk for sarcopenia and physical disability
is greater in older patients with type 2 diabetes mellitus (T2DM)
[2]. The biological mechanisms associated with accelerated loss of
muscle remain uncertain but alterations in skeletal muscle protein
turnover are clearly implicated in such modifications in T2DMwithAintree University Hospital,
k (D.J. Cuthbertson).
n open access article under the CCevidence of impaired stimulation of protein synthesis related to
ageing and insulin resistance [3,4].
We determined whether an impaired anabolic response to
feeding (with essential amino acids, (EAA)) was evident in skeletal
muscle of older patients with T2D and whether diminished
anabolic sensing and signalling through the PKB/mTOR pathway
was implicated in any impairment.
2. Methods
2.1. Participant characteristics
Twelve healthy older men and eight men with T2DM were
recruited (age 68 ± 3 vs. 68 ± 6 y; BMI: 30 ± 2 vs. 27 ± 5 kg m2). All
subjects gave informed written consent and the study wasBY license (http://creativecommons.org/licenses/by/4.0/).
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Detailed information on inclusion and exclusion criteria is reported
in the online supplemental material.
Height and weight were measured and body mass indices and
body surface areas were determined. Dual energy photon X-ray
absorptiometry (DEXA; HOLOGIC Discovery W, Bedford, MA) was
used to determine whole-body and appendicular lean (ALM) and
fat (FM) masses. Age, gender and body mass index (BMI)-specific
reference curves were used to calculate the individual percentile for
height-adjusted ALM (appendicular lean mass index, ALMI) and FM
(fat mass index, FMI) according to Prado et al. [5].
2.2. Experimental protocol
Myofibrillar and sarcoplasmic protein FSR under basal, post-
absorptive conditions (0e3 h) and after stimulation by EAA
(3e6 h) were measured. In all cases a prior 0.5 h period (0.5e0 h)
ensured a plateau enrichment of the stable isotope. A protocol
schematic and the composition of the oral EAAs that participants
were fed is provided in the online supplemental material (Fig. S1).
2.3. Analytical methods
More detailed information on the analytical procedures are re-
ported in the online supplemental material but methods are
described briefly below.
Plasma glucose was measured with a YSI Stat2300 (Yellow
Spring Instruments, Yellow Spring, OH) immediately after collec-
tion of each sample. Insulin was determined using an Abbott IMx
analyzer (Abbott Inc Deerfield, IL, USA), based upon a microparticle
enzyme immunoassay.
The labelling of leucine in plasma and free muscle water was
determined by GC-MS after conversion to the t- BDMS derivative;
the 13C/12C ratio of leucine was determined by selected-ion moni-
toring MS by standard methods as previously described. Plasma
amino acids were quantified as their t-BDMS derivative after the
addition of norleucine as internal standard.
Frozen muscle was processed in buffer containing inhibitors of
phosphatase and protease activity (e.g. vanadate and microcystine)
to maintain the phosphorylation state of the sarcoplasmic fraction
signalling proteins. Samples (60e80 mg) were processed to sepa-
rate myofibrillar and sarcoplasmic protein as described previously.
We estimated the relative concentrations and extent of phos-
phorylation using Western blotting in the basal state and after
stimulation by EAA examining components of the mammalian
target of rapamycin (mTOR) signalling pathway, known to be
important for regulation of mammalian MPS.
2.4. Statistical analysis
Patient/subject anthropometric, body composition characteris-
tics and biochemical concentrations were compared using an un-
paired t-test. One-way ANOVAwithmultiple data sets were applied
for the FSR measurements with Bonferroni post test procedures for
comparison of groupmeans. Pwas taken as being significant at 0.05
or less. Values are given as mean ± SD.
3. Results
3.1. Body composition
The T2DM group had a significantly greater percentage body fat
(33 ± 2 vs. 24 ± 5%; p < 0.001) compared to controls but the two
groups had similar total (P ¼ 0.84) and appendicular lean mass
(P ¼ 0.60) (Table S1, online supplemental material). However, withapplication of age, gender and BMI-specific models of body
composition, significant differences between the two groups
emerged using percentiles for FMI and ALMI. T2DM patients had
higher FMI (49.8 ± 26.4 vs. 16.0 ± 14.9; P ¼ 0.003) and lower ALMI
(34.0 ± 29.5 vs. 66.2 ± 31.3; P ¼ 0.04) percentiles compared to the
controls, respectively (Fig. 1A).
3.2. Biochemical characteristics
Fasting plasma glucose and insulin concentration were main-
tained at the post-absorptive concentration throughout the dura-
tion of the study. There was a significant difference between
the plateau glucose and plateau insulin concentrations in the
T2DM patients and the elderly (both p < 0.001) (Fig. 2, online
supplemental material).
3.3. Rates of protein synthesis
Basal myofibrillar and sarcoplasmic FSR were similar between
groups. Myofibrillar FSRwas not significantly different after feeding
either 10 or 20 g EAA between the controls and T2DM. The same
pattern of anabolic stimulationwas observed in controls and T2DM
in that 10 g EAA significantly stimulated myofibrillar MPS with no
additional stimulation with 20 g beyond that seen with 10 g EAA
(Fig. 1B). Sarcoplasmic FSR was similar between the control and
T2DM after 10 g EAA. After 20 g EAA, there was reduced respon-
siveness of sarcoplasmic protein in T2DM compared with the
control (Fig. 1C).
3.4. Signalling protein analysis
In T2DM the concentration of p70S6k was reduced to 0.76 ± 0.06
of control (P < 0.01) but mTOR and 4E-BP1 were similar. Feeding
20 g EAA increased phosphorylation of mTOR, p70S6k and 4E-BP1
by 60e100% without any effect in T2DM (P < 0.05) (Fig. 2).
4. Discussion
We have shown that in obese older patients with T2DM and
good glycaemic control, rates of myofibrillar or sarcoplasmic mus-
cle protein synthesis were similar to those in age-matched, non-
diabetic individuals. Only the stimulation of sarcoplasmic protein
synthesis, in response to the highest dose (20 g) of EAA, was
blunted in the patients with T2DM. Despite the similarity in the
anabolic response of MPS to feeding, there was diminished phos-
phorylation of the proteins involved in amino acid sensing/signal-
ling pathways, namely mTOR, p70S6k and 4E-BP1 in patients with
T2DM compared with controls.
In examining the effects of feeding in T2DM, several patho-
physiological considerations beyond that of ageing must be
accounted for, particularly the degree of insulin resistance. Recently
there have been conflicting results regarding the magnitude of the
anabolic response to feeding in non-diabetic individuals in the
presence of acute lipid-induced insulin resistance. Stephens et al.,
demonstrated anabolic resistance to a bolus of oral amino acids
when muscle lipid was increased during a lipid infusion in young
men [6]. In contrast, others have found that elevated circulating
free fatty acid concentrations do not impair the anabolic response
to feeding [7].
However, it has been reported that T2DM hyperaminoacidaemia
stimulates rates of whole body or skeletal muscle protein synthesis
to a similar extent to those observed in lean and weight-matched
control subjects [8]. In the current study, the influence of insulin
resistance has been removed bymaintaining insulin concentrations
Fig. 1. Patients with T2DM, despite greater body weight, higher fat mass and a higher
percentile of fat mass index (FMI) had more pronounced sarcopenia with a signifi-
cantly lower percentile appendicular lean mass index (ALMI) than the healthy controls
(Fig. 1A). Myofibrillar (Fig. 1B) and sarcoplasmic (Fig. 1C) fractional synthesis rates
(FSR) in the post-absorptive state and in response to 10 g and 20 g EAA, in the healthy
elderly (open bars) (n ¼ 12) and in patients with T2D (cross-hatched bars) (n ¼ 8).
Values are mean ± SD; *P < 0.001 compared to fasted; yP < 0.01 compared to 10 g;
yyP < 0.01 compared to old.
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Fig. 2. Western blot analysis of phospho-specific mTOR, p70S6k and 4E-BP1 in fasting
and fed conditions in healthy elderly and T2D in response to 20 g EAA. Values are
mean ± SD; *P < 0.05.
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isolated effect of hyperaminoacidaemia.
In patients with T2DM, we observed a diminution of the acti-
vation of mTOR, p70S6k and 4E-BP1, despite apparently similar rates
of myofibrillar protein synthesis to those in the healthy older
people and attenuated rates of sarcoplasmic protein synthesis only
in response to the highest dose of EAA. We have previously
demonstrated that in older people, only basal, post-absorptive in-
sulin concentrations accompanying ingestion of EAA is required to
significantly activate themTOR signalling pathway and sowemight
expect similar activation of this pathway in both groups [4]. Para-
doxically, stimulation of MPS in diabetic rats has been demon-
strated to occur in the absence of increases in the phosphorylation
of components of the mTOR pathway (4E-BP1 and p70S6k) sug-
gesting there may be alternate, insulin-independent, signal trans-
duction pathways that mediate changes in MPS. However we have
also noted a lack of a coherent response between the activation of
signalling proteins regulating translation initiation and directly
measured rates of protein synthesis in human muscle in previous
studies [9,10].
These findings suggest that the mechanism underlying accel-
erated muscle loss in T2DM does not involve anabolic resistance to
feeding. Similarly, evidence of anabolic resistance to exercise in
D.J. Cuthbertson et al. / Clinical Nutrition 36 (2017) 1716e1719 1719T2DM is lacking considering the findings from exercise in-
terventions in obese T2DM in which the magnitude of accretion of
muscle mass is similar to that observed in healthy controls [12].
Taking these data together, it might be speculated that the more
pronounced muscle loss in T2DM perhaps reflects greater levels of
physical inactivity in T2DM compared to age-matched healthy
controls; individuals with T2DM have a demonstrably more
sedentary lifestyle than age-matched healthy controls [11]. In the
absence of measures of the participants' habitual physical activity,
the mechanism underlying the reduced lean body mass in those
with type 2 diabetes versus healthy controls can only be speculated
in the current study but is likely to involve reduced physical activity
in those with type 2 diabetes.
In conclusion, we demonstrate that despite evidence of aberrant
mTOR signalling responses to feeding in obese patients with T2DM,
compared to overweight non-diabetic controls, the anabolic
response to feeding is similar in T2DM and controls. Thus, the re-
sults suggest that anabolic resistance to feeding may not be
responsible for the accelerated muscle loss observed in T2DM with
mechanisms linked to reduced physical activity potentially
contributory.
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